Nebulization of niosomal all-trans-retinoic acid: An inexpensive alternative to conventional liposomes

International Journal of Pharmaceutics

Volumn 241, Issue 2, 2002, Pages 311-317

  Desai, Tejas R ^a   Finlay, Warren H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Aerosols; All trans retinoic acid; Nebulization; Niosomes

Indexed keywords

LIPOSOME; NIOSOME; POLYSORBATE 80; RETINOIC ACID; SORBITAN LAURATE; SORBITAN STEARATE;

AEROSOL; ARTICLE; DEVICE; DRUG COST; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; ENCAPSULATION; EVAPORATION; INHALATION; MEDICAL NEBULIZER; NEBULIZATION; PARTICLE SIZE; PRIORITY JOURNAL; STANDARD;

CHEMISTRY, PHARMACEUTICAL; LIPOSOMES; NEBULIZERS AND VAPORIZERS; TRETINOIN;

EID: 0037173523     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00245-4     Document Type: Article

References (31)

1. In vitro incorporation of release of hydroxycobalamin by liposomes
2. Phase II study of all-trans-retinoic acid and α-interferon in patients with advanced non-small cell lung cancer
3. The effect of nonionic surfactant vesicle (niosomes) entrapment on the absorption and distribution of methotrexate in mice
4. Preparation and properties of niosomes - Nonionic vesicle
5. Regional lung deposition of nebulized liposome encapsulated ciprofloxacin
6. Undersizing of droplets from a vented nebulizer caused by aerosol heating during transit through an Anderson impactor
7. Lung delivery of aerosolized dextran
8. Aerosol and intraperitoneal administration of ribavarin and ribavarin triacetate: Pharamcokinetics and protection of mice against intracerebral infection with influenza A/WSN virus
9. Retinoids and human cancer
10. Preparation and characterization of niosomes containing rifampicin for lung targeting
11. The effect of charge and cholesterol on the size and thickness of phospholipid vesicles
12. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer
13. In vitro delivery and regional airway surface liquid concentration of a liposomal cationic peptide
14. Retinoids as preventive and therapeutic anticancer agents
15. Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell lines
16. Pharmacokinetics, tissue distribution and toxicology of tretinoin incorporated in liposomes
17. Use of all-trans-retinoic acid in treatment of acute promyelocytic leukemia
18. Nebulization of liposomes. III. The effects of operating conditions and local environment
19. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small lung cancer
20. Aerosol delivery of liposomal all-trans-retinoic acid to the lungs
21. Enhanced inhibition of platelet aggregation in-vitro by niosome encapsulated indomethacin
22. Adriamycin loaded niosomes: Drug entrapment, stability and release
23. The distribution of doxorubicin in mice following administration in niosomes
24. Retinoids as chemopreventive and therapeutic agents
25. The stability of liposomes to nebulization
26. Phase II trial of all-trans-retinoic acid in metastatic non-small cell lung cancer
27. Nonionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry
28. The nonclinical safety evaluation of the anticancer drug ATRAGEN™ (liposomal all-trans-retinoic acid)
29. Differences in the lipoprotein distribution of free and liposome-associated aa-trans-retinoic acid in human, dog and rat plasma are due to variations in lipoprotein lipid and protein content
30. Liposomes as drug carriers in cancer chemotherapy